Scientists Discover Exercise Protein Reversing Muscle Bone Aging

Recent research highlights promising advances in combating age-related decline through exercise, drugs, and supplements. South Korean scientists discovered that the protein CLCF1, released during resistance training, can reverse muscle and bone aging, offering a potential new treatment avenue for frailty and osteoporosis. Meanwhile, the pharmaceutical industry eyes over $30 billion in sales by 2035 for muscle-preserving drugs designed to complement popular GLP-1 obesity treatments like Lilly's Zepbound and Novo Nordisk's Wegovy, addressing concerns about muscle loss during weight reduction. Additionally, a natural supplement containing plant-based ingredients demonstrated the ability to reduce biological age and improve physical and epigenetic markers of aging in a year-long clinical trial. Complementing these approaches, a large meta-analysis revealed that the anti-aging drug rapamycin matches the effectiveness of calorie restriction and intermittent fasting in protecting cells and cognitive function, positioning it as a promising pharmacological strategy to promote healthy aging without the challenges of strict diets. Together, these findings underscore a multifaceted approach to slowing and potentially reversing aspects of biological aging.